Repligen (RGEN) Capital Expenditures (2010 - 2026)
Repligen (RGEN) posted quarterly Capital Expenditures of $5.3 million for Q2 2026, down 24.88% year-over-year from $7.1 million in Q2 2025, and up 13.25% quarter-over-quarter from $4.7 million in Q1 2026.
Repligen (RGEN) Capital Expenditures (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Capital Expenditures for 17 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 24.88% year-over-year to $5.3 million; the TTM figure through Jun 2026 stood at $22.9 million (down 1.24% YoY), while the FY2025 annual figure was $23.5 million, down 8.4% from the prior year.
- Capital Expenditures climbed to $5.3 million in Q2 2026 per RGEN's latest filing, from $4.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $27.2 million in Q1 2022 and bottomed at $3.6 million in Q1 2025.
- Historically, Capital Expenditures has averaged $10.0 million across 5 years, with a median of $8.2 million in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 258.7% — and 2023, when it plunged 68.72%.
- Repligen's Capital Expenditures stood at $20.4 million in 2022, then sank by 45.77% to $11.1 million in 2023, then plunged by 50.03% to $5.5 million in 2024, then surged by 47.17% to $8.2 million in 2025, then sank by 34.58% to $5.3 million in 2026.
- Business Quant data shows RGEN's Capital Expenditures at $5.3 million in Q2 2026, $4.7 million in Q1 2026, and $8.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33 Mn |
| Jun 30, 2026 | 5.33 Mn |
| Mar 31, 2026 | 4.71 Mn |
| Mar 31, 2026 | 4.71 Mn |
| Dec 31, 2025 | 8.15 Mn |
| Dec 31, 2025 | 8.15 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Mar 31, 2024 | 8.35 Mn |
| Mar 31, 2024 | 8.35 Mn |